Vitamin C 'Cures' Mice With Accelerated Aging Disease

ScienceDaily (Jan. 4, 2010) — A new research discovery published in the January 2010 print issue of the FASEB Journal suggests that treatments for disorders that cause accelerated aging, particularly Werner's syndrome, might come straight from the family medicine chest. In the research report, a team of Canadian scientists shows that vitamin C stops and even reverses accelerated aging in a mouse model of Werner's syndrome, but the discovery may also be applicable to other progeroid syndromes.

---

See Also:

Health & Medicine

• Healthy Aging
• Vitamin
• Vitamin C
• Vitamin Dvitamin c
• Dietary Supplement
• Vitamin E

People with Werner's syndrome begin to show signs of accelerated aging in their 20s and develop age-related diseases and generally die before the age of 50.
"Our study clearly indicates that a healthy organism or individuals with no health problems do not require a large amount of vitamin C in order to increase their lifespan, especially if they have a balanced diet and they exercise," said Michel Lebel, Ph.D., co-author of the study from the Centre de Recherche en Cancerologie in Quebec, Canada. "An organism or individual with a mutation in the WRN gene or any gene affected by the WRN protein, and thus predisposes them to several age-related diseases, may benefit from a diet with the appropriate amount of vitamin C."
Scientists treated both normal mice and mice with a mutation in the gene responsible for Werner's syndrome (WRN gene) with vitamin C in drinking water. Before treatment, the mice with a mutated WRN gene were fat, diabetic, and developing heart disease and cancer. After treatment, the mutant mice were as healthy as the normal mice and lived a normal lifespan. Vitamin C also improved how the mice stored and burned fat, decreased tissue inflammation and decreased oxidative stress in the WRN mice. The healthy mice did not appear to benefit from vitamin C.
"Vitamin C has become one of the most misunderstood substances in our medicine cabinets and food," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "This study and others like it help explain how and why this chemical can help to defend some, but certainly not all, people from premature senescence

Soon after the exciting discovery of a method to turn human adult cells into stem cells in 2007 came the frustration of actually trying to make that transformation efficient. In creating induced pluripotent stem (iPS) cells, scientists typically only get 0.01 percent of a sample of human fibroblast (skin) cells to change. A group led by Duanqing Pei of the Guangzhou Institutes of Biomedicine and Health in China has found that a simple chemical can boost the efficiency by 100-fold—namely, vitamin C. The researchers can trigger the conversion to iPS cells by introducing genes or proteins to adult cells, typically with a virus. Once the cells become pluripotent, they have the ability to become any cell in the body, thereby offering the promise of repairing damaged organs and treating disease. But scientists have yet to come up with the ideal recipe. “It’s a worldwide effort to boost efficiency and make this more practical for much wider participation from the scientific community,” Pei says. In their effort, Pei and his group started with the realization that the factors that induce cells to become pluripotent were causing the cells to make the free radicals known as reactive oxygen species (ROS). “A high level of ROS is definitely very bad for the fibroblasts,” Pei notes, because it speeds cell death. To fight off the ROS, Pei’s team tested a variety of antioxidant chemicals in the cells’ growing medium. Experimenting with mouse cells, the group found that the petri dish containing vitamin C had 30 percent more mouse cells than the dish that did not, suggesting that the antioxidant helped to ward off the effects of aging. Surprisingly, vitamin C not only helped cells survive, but it also enhanced their progression to pluripotency. After 14 days, when cells start to become fully pluripotent, 10 to 20 percent of the mouse cells that were grown with vitamin C expressed genes associated with pluripotency, compared with only 0.1 to 0.2 percent of the colonies grown without vitamin C. The group saw a similar improvement in human fibroblast reprogramming, in which ascorbic acid boosted the conversion rate from 0.01 to 1 percent. The researchers, who published their findings in the December 24 Cell Stem Cell, also tested other antioxidants, but none boosted the development of pluripotency the way vitamin C did. That has lead Pei to believe that, in addition to ascorbic acid’s antioxidant property, an as yet unknown mechanism plays a role. And although more detailed analysis is needed, having vitamin C around does not seem to introduce negative cellular changes. “Overall, I think this is quite impressive progress,” remarks Kwang-Soo Kim, director of the Molecular Neurobiology Lab at Harvard Medical School. Although 1 percent may not seem all that efficient, it could be enough to push the field significantly. “We don’t need to generate 50 percent of the cells,” Kim says, “as long as we can reproducibly generate a sufficient number of iPS lines.”

Soon after the exciting discovery of a method to turn human adult cells into stem cells in 2007 came the frustration of actually trying to make that transformation efficient. In creating induced pluripotent stem (iPS) cells, scientists typically only get 0.01 percent of a sample of human fibroblast (skin) cells to change.
A group led by Duanqing Pei of the Guangzhou Institutes of Biomedicine and Health in China has found that a simple chemical can boost the efficiency by 100-fold—namely, vitamin C.
The researchers can trigger the conversion to iPS cells by introducing genes or proteins to adult cells, typically with a virus. Once the cells become pluripotent, they have the ability to become any cell in the body, thereby offering the promise of repairing damaged organs and treating disease. But scientists have yet to come up with the ideal recipe. “It’s a worldwide effort to boost efficiency and make this more practical for much wider participation from the scientific community,” Pei says.
In their effort, Pei and his group started with the realization that the factors that induce cells to become pluripotent were causing the cells to make the free radicals known as reactive oxygen species (ROS). “A high level of ROS is definitely very bad for the fibroblasts,” Pei notes, because it speeds cell death. To fight off the ROS, Pei’s team tested a variety of antioxidant chemicals in the cells’ growing medium. Experimenting with mouse cells, the group found that the petri dish containing vitamin C had 30 percent more mouse cells than the dish that did not, suggesting that the antioxidant helped to ward off the effects of aging.
Surprisingly, vitamin C not only helped cells survive, but it also enhanced their progression to pluripotency. After 14 days, when cells start to become fully pluripotent, 10 to 20 percent of the mouse cells that were grown with vitamin C expressed genes associated with pluripotency, compared with only 0.1 to 0.2 percent of the colonies grown without vitamin C. The group saw a similar improvement in human fibroblast reprogramming, in which ascorbic acid boosted the conversion rate from 0.01 to 1 percent.
The researchers, who published their findings in the December 24 Cell Stem Cell, also tested other antioxidants, but none boosted the development of pluripotency the way vitamin C did. That has lead Pei to believe that, in addition to ascorbic acid’s antioxidant property, an as yet unknown mechanism plays a role. And although more detailed analysis is needed, having vitamin C around does not seem to introduce negative cellular changes.
“Overall, I think this is quite impressive progress,” remarks Kwang-Soo Kim, director of the Molecular Neurobiology Lab at Harvard Medical School. Although 1 percent may not seem all that efficient, it could be enough to push the field significantly. “We don’t need to generate 50 percent of the cells,” Kim says, “as long as we can reproducibly generate a sufficient number of iPS lines.”